NCT03557892View on ClinicalTrials.gov

Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

December 20, 2019

Study Completion Date

January 2, 2020

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

CGM+CSII

Animas Vibe Platinum insulin pump and Dexcom G4 CGM

DEVICE

MDI with degludec

Multiple injection therapy with any short-acting analogue as bolus insulin and degludec as basal insulin

Trial Locations (1)

50134

Diabetologia AOU Careggi, Florence

All Listed Sponsors
lead

Azienda Ospedaliero-Universitaria Careggi

OTHER

NCT03557892 - Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes | Biotech Hunter | Biotech Hunter